Prevalence and risk factors of vertebral compression fractures in female SLE patients

Arthritis Research and Therapy

Volumn 12, Issue 4, 2010, Pages

  Almehed, Katarina ^a   Hetényi, Szabolcs ^b,c   Ohlsson, Claes ^a   Carlsten, Hans ^a   Forsblad d'Elia, Helena ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c European Telemedicine Clinic SL Body Section   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; COLECALCIFEROL; GLUCOCORTICOID;

ADULT; AGED; AGING; ARTICLE; BONE DENSITY; COMPRESSION FRACTURE; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DRUG USE; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HUMAN; LUMBAR SPINE; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PREVALENCE; RISK FACTOR; SPINE RADIOGRAPHY; SWEDEN; SYSTEMIC LUPUS ERYTHEMATOSUS; THORACIC SPINE; VERTEBRA FRACTURE; INJURY; LUMBAR VERTEBRA; MIDDLE AGED; SPINE FRACTURE; VERTEBRA;

ADULT; AGED; AGED, 80 AND OVER; BONE DENSITY; FEMALE; FRACTURES, COMPRESSION; HUMANS; LUMBAR VERTEBRAE; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; PREVALENCE; RISK FACTORS; SPINAL FRACTURES; SWEDEN; THORACIC VERTEBRAE; YOUNG ADULT;

EID: 77955071348     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar3104     Document Type: Article

References (33)

1. Rhew EY, Lee C, Eksarko P, Dyer AR, Tily H, Spies S, Pope RM, Ramsey-Goldman R. Homocysteine, bone mineral density, and fracture risk over 2 years of followup in women with and without systemic lupus erythematosus. J Rheumatol 2008, 35:230-236.
2. Borba VZ, Matos PG, da Silva Viana PR, Fernandes A, Sato EI, Lazaretti-Castro M. High prevalence of vertebral deformity in premenopausal systemic lupus erythematosus patients. Lupus 2005, 14:529-533. 10.1191/0961203305lu2154oa, 16130509.
3. Ramsey-Goldman R, Dunn JE, Huang CF, Dunlop D, Rairie JE, Fitzgerald S, Manzi S. Frequency of fractures in women with systemic lupus erythematosus: comparison with United States population data. Arthritis Rheum 1999, 42:882-890. 10.1002/1529-0131(199905)42:5<882::AID-ANR6>3.0.CO;2-C, 10323443.
4. Ismail AA, Cooper C, Felsenberg D, Varlow J, Kanis JA, Silman AJ, O'Neill TW. Number and type of vertebral deformities: epidemiological characteristics and relation to back pain and height loss. European Vertebral Osteoporosis Study Group. Osteoporos Int 1999, 9:206-213. 10.1007/s001980050138, 10450408.
5. Lems WF. Clinical relevance of vertebral fractures. Ann Rheum Dis 2007, 66:2-4. 10.1136/ard.2006.058313, 1798393, 17178757.
6. Canalis E. Mechanisms of glucocorticoid-induced osteoporosis. Curr Opin Rheumatol 2003, 15:454-457. 10.1097/00002281-200307000-00013, 12819474.
7. O'Brien CA, Jia D, Plotkin LI, Bellido T, Powers CC, Stewart SA, Manolagas SC, Weinstein RS. Glucocorticoids act directly on osteoblasts and osteocytes to induce their apoptosis and reduce bone formation and strength. Endocrinology 2004, 145:1835-1841. 10.1210/en.2003-0990, 14691012.
8. Kanis JA, Johnell O, Oden A, Borgstrom F, Zethraeus N, De Laet C, Jonsson B. The risk and burden of vertebral fractures in Sweden. Osteoporos Int 2004, 15:20-26. 10.1007/s00198-003-1463-7, 14593450.
9. Medeiros MM, Silveira VA, Menezes AP, Carvalho RC. Risk factors for ovarian failure in patients with systemic lupus erythematosus. Braz J Med Biol Res 2001, 34:1561-1568. 10.1590/S0100-879X2001001200008, 11717709.
10. Finkelstein JS, Brockwell SE, Mehta V, Greendale GA, Sowers MR, Ettinger B, Lo JC, Johnston JM, Cauley JA, Danielson ME, Neer RM. Bone mineral density changes during the menopause transition in a multi-ethnic cohort of women. J Clin Endocrinol Metab 2007, 2266953, 18160467.
11. Lips P. Vitamin D physiology. Prog Biophys Mol Biol 2006, 92:4-8. 10.1016/j.pbiomolbio.2006.02.016, 16563471.
12. van Schoor NM, Visser M, Pluijm SM, Kuchuk N, Smit JH, Lips P. Vitamin D deficiency as a risk factor for osteoporotic fractures. Bone 2008, 42:260-266. 10.1016/j.bone.2007.11.002, 18289505.
13. Lee C, Almagor O, Dunlop DD, Manzi S, Spies S, Ramsey-Goldman R. Self-reported fractures and associated factors in women with systemic lupus erythematosus. J Rheumatol 2007, 34:2018-2023.
14. Almehed K, Forsblad d'Elia H, Kvist G, Ohlsson C, Carlsten H. Prevalence and risk factors of osteoporosis in female SLE patients-extended report. Rheumatology (Oxford) 2007, 46:1185-1190. 10.1093/rheumatology/kem105, 17500075.
15. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982, 25:1271-1277. 10.1002/art.1780251101, 7138600.
16. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 1992, 35:630-640. 10.1002/art.1780350606, 1599520.
17. Gladman DD, Urowitz MB, Goldsmith CH, Fortin P, Ginzler E, Gordon C, Hanly JG, Isenberg DA, Kalunian K, Nived O, Petri M, Sanchez-Guerrero J, Snaith M, Sturfelt G. The reliability of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index in patients with systemic lupus erythematosus. Arthritis Rheum 1997, 40:809-813. 10.1002/art.1780400506, 9153540.
18. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976, 16:31-41. 10.1159/000180580, 1244564.
19. Genant HK, Wu CY, van Kuijk C, Nevitt MC. Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res 1993, 8:1137-1148. 10.1002/jbmr.5650080915, 8237484.
20. Kanis JA, Melton LJ, Christiansen C, Johnston CC, Khaltaev N. The diagnosis of osteoporosis. J Bone Miner Res 1994, 9:1137-1141. 10.1002/jbmr.5650090802, 7976495.
21. O'Neill TW, Felsenberg D, Varlow J, Cooper C, Kanis JA, Silman AJ. The prevalence of vertebral deformity in european men and women: the European Vertebral Osteoporosis Study. J Bone Miner Res 1996, 11:1010-1018. 10.1002/jbmr.5650110719, 8797123.
22. Bultink IE, Lems WF, Kostense PJ, Dijkmans BA, Voskuyl AE. Prevalence of and risk factors for low bone mineral density and vertebral fractures in patients with systemic lupus erythematosus. Arthritis Rheum 2005, 52:2044-2050. 10.1002/art.21110, 15986345.
23. Li EK, Tam LS, Griffith JF, Zhu TY, Li TK, Li M, Wong KC, Chan M, Lam CW, Chu FS, Wong KK, Leung PC, Kwok A. High prevalence of asymptomatic vertebral fractures in Chinese women with systemic lupus erythematosus. J Rheumatol 2009, 36:1646-1652. 10.3899/jrheum.081337, 19605677.
24. Angeli A, Guglielmi G, Dovio A, Capelli G, de Feo D, Giannini S, Giorgino R, Moro L, Giustina A. High prevalence of asymptomatic vertebral fractures in post-menopausal women receiving chronic glucocorticoid therapy: a cross-sectional outpatient study. Bone 2006, 39:253-259. 10.1016/j.bone.2006.02.005, 16574519.
25. Samelson EJ, Hannan MT, Zhang Y, Genant HK, Felson DT, Kiel DP. Incidence and risk factors for vertebral fracture in women and men: 25-year follow-up results from the population-based Framingham study. J Bone Miner Res 2006, 21:1207-1214. 10.1359/jbmr.060513, 16869718.
26. Yee CS, Crabtree N, Skan J, Amft N, Bowman S, Situnayake D, Gordon C. Prevalence and predictors of fragility fractures in systemic lupus erythematosus. Ann Rheum Dis 2005, 64:111-113. 10.1136/ard.2003.018127, 1755180, 15608308.
27. Lofman O, Hallberg I, Berglund K, Wahlstrom O, Kartous L, Rosenqvist AM, Larsson L, Toss G. Women with low-energy fracture should be investigated for osteoporosis. Acta Orthop 2007, 78:813-821. 10.1080/17453670710014608, 18236189.
28. Mendoza-Pinto C, Garcia-Carrasco M, Sandoval-Cruz H, Munoz-Guarneros M, Escarcega RO, Jimenez-Hernandez M, Munguia-Realpozo P, Sandoval-Cruz M, Deleze-Hinojosa M, Lopez-Colombo A, Cervera R. Risk factors of vertebral fractures in women with systemic lupus erythematosus. Clin Rheumatol 2009, 28:579-585. 10.1007/s10067-009-1105-3, 19224131.
29. Stellon AJ, Webb A, Compston JE. Bone histomorphometry and structure in corticosteroid treated chronic active hepatitis. Gut 1988, 29:378-384. 10.1136/gut.29.3.378, 1433621, 3356370.
30. Cummings SR, Ensrud K, Delmas PD, LaCroix AZ, Vukicevic S, Reid DM, Goldstein S, Sriram U, Lee A, Thompson J, Armstrong RA, Thompson DD, Powles T, Zanchetta J, Kendler D, Neven P, Eastell R. Lasofoxifene in postmenopausal women with osteoporosis. N Engl J Med 362:686-696. 10.1056/NEJMoa0808692, 20181970.
31. Cummings SR, San Martin J, McClung MR, Siris ES, Eastell R, Reid IR, Delmas P, Zoog HB, Austin M, Wang A, Kutilek S, Adami S, Zanchetta J, Libanati C, Siddhanti S, Christiansen C. Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med 2009, 361:756-765. 10.1056/NEJMoa0809493, 19671655.
32. Black DM, Palermo L, Nevitt MC, Genant HK, Epstein R, San Valentin R, Cummings SR. Comparison of methods for defining prevalent vertebral deformities: the study of osteoporotic fractures. J Bone Miner Res 1995, 10:890-902. 10.1002/jbmr.5650100610, 7572313.
33. Briggs AM, Greig AM, Wark JD. The vertebral fracture cascade in osteoporosis: a review of aetiopathogenesis. Osteoporos Int 2007, 18:575-584. 10.1007/s00198-006-0304-x, 17206492.